Hexarelin* · Examorelin*
Researchers seeking this product for laboratory research can explore PepGen-X.com as a supplier specializing in research-use compounds.
Hexarelin, also known as Examorelin, is a synthetic growth hormone-releasing peptide (GHRP) known for producing a strong growth hormone response. Its research profile includes endocrine signaling, GH regulation, and investigations into cardiovascular and tissue-related pathways.
Research Benefits
Powerful GH stimulation – Produces a pronounced growth hormone response in experimental research.
Endocrine signaling research – Provides a well-established model for investigating growth hormone secretagogue activity.
GH pathway research – Supports investigation of the relationship between GH release and downstream signaling.
Cardiovascular research – Experimental studies have investigated Hexarelin and related pathways in cardiac tissue and cardiovascular biology.
Tissue & recovery research – GH-related signaling has generated interest in muscle and tissue biology.
Comparative secretagogue research – Provides a useful model for studying potent GHRP activity and broader endocrine responses.
Identified Risks & Side Effects
Cortisol and prolactin effects – Hexarelin may influence endocrine pathways beyond growth hormone.
Desensitization – Reduced responsiveness may develop with repeated or prolonged exposure.
Fluid retention – Water retention or edema may occur with increased GH activity.
Appetite and fatigue – Changes in appetite or fatigue have been reported with GH secretagogue activity.
Glucose metabolism – Increased GH signaling may influence glucose regulation.
Long-term uncertainty – Long-term safety has not been established.
Route: Experimental, commonly subcutaneous in research | Frequency: Varies by research protocol | FDA Status: Not FDA-approved
Researcher Note
Hexarelin is notable for its strong growth hormone-releasing activity and broad research profile. Its effects on cardiovascular and tissue-related pathways are particularly interesting areas of investigation, although evidence from preclinical research should be distinguished from established human outcomes.
Disclaimer
FDA Status: Not FDA-approved
Research Classification: Research use only
Compound Type: Synthetic growth hormone secretagogue
All products are intended strictly for research and laboratory use only and are not intended for human or veterinary use.